Atlas Trials

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT04504942 · COMPLETED

Trial details

NCT number
NCT04504942
Sponsor
CytoDyn, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Solid Tumor, Adult
Start date
2020-05-01
Primary completion
2021-11-07
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.